Rege Nephro

Kyoto, Japan

Rege Nephro is a biotech company that specializes in R&D, production, and marketing of renal disease therapeutics.

$15.2M raised

Oct 2024

Series B

Biotechnology Manufacturing Medical Rental

Top Investors

Mitsubishi UFJ CapitalGlobal Brain CorporationSMBC Venture CapitalJIC Venture Growth InvestmentsSenshu Ikeda Capital

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Rege Nephro

How much funding has Rege Nephro raised?

Rege Nephro has raised $15.2M in total funding. The most recent round was Series B. The last funding was announced in October 2024.

Who are Rege Nephro's investors?

Rege Nephro's investors include Mitsubishi UFJ Capital, Global Brain Corporation, SMBC Venture Capital, JIC Venture Growth Investments, Senshu Ikeda Capital.

Where is Rege Nephro headquartered?

Rege Nephro is headquartered in Kyoto, Japan.

What does Rege Nephro do?

Rege Nephro is a biotech company that specializes in R&D, production, and marketing of renal disease therapeutics.

What stage is Rege Nephro at?

Rege Nephro is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated October 7, 2024.

MLA

"Rege Nephro — Funding & Investors." VCBacked, October 7, 2024, https://www.vcbacked.co/company/rege-nephro. Accessed June 4, 2026.

APA

VCBacked. (2024). Rege Nephro — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/rege-nephro

Wikipedia (cite web)

{{cite web |title=Rege Nephro — Funding & Investors |url=https://www.vcbacked.co/company/rege-nephro |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated October 7, 2024.

Similar Companies in Biotechnology